<a href="https://pixabay.com/users/terimakasih0/">terimakasih0</a> / Pixabay
First Patient Dosed in Clinical Trial for Usher Syndrome Type 2
According to a story from globenewswire.com, ProQR Therapeutics N.V. recently announced that it has begun dosing patients in its Phase 1/2 clinical trial. This trial is testing the company's investigational…
